Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(7), P. 921 - 921
Published: July 10, 2024
The
gut
microbiota
is
closely
associated
with
human
health,
and
alterations
in
can
influence
various
physiological
pathological
activities
the
body.
Therefore,
regulation
has
become
an
important
strategy
current
disease
treatment,
albeit
facing
numerous
challenges.
Nanomaterials,
owing
to
their
excellent
protective
properties,
drug
release
capabilities,
targeting
abilities,
good
biocompatibility,
have
been
widely
developed
utilized
pharmaceuticals
dietary
fields.
In
recent
years,
significant
progress
made
research
on
utilizing
nanomaterials
assist
regulating
for
intervention.
This
review
explores
latest
advancements
application
of
offers
insights
into
future
development
modulating
microbiota.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
Orally
targeting
nanostrategies
of
multiple
nutraceuticals
have
attracted
increasing
attention
in
ulcerative
colitis
(UC)
therapy
for
superior
patient
compliance,
cost-effectiveness,
and
biocompatibility.
However,
the
actual
delivery
bioefficacy
are
extremely
restricted
by
their
poor
solubility,
interior
gastrointestinal
retention,
base
permeability.
Herein,
we
developed
controllable
colon-targeting
nanoparticles
(NPs)
composed
a
quaternary
ammonium
chitosan
(HTCC)
shell
succinic
acid-modified
γ-cyclodextrin
(SACD)
core
precise
UC
treatment.
Egg
white-derived
peptides
(EWDP,
typical
food-derived
peptides)
could
not
only
function
as
potential
cross-linkers
to
induce
differential
coassembly
with
above
biopolymers
but
also
aid
hydrophobic
curcumin
(Cur)
solubility
well
nutrition
enhancers
oral
synergism
therapy.
More
specifically,
NPs
higher
EWDP
efficiency
exhibited
better
pH-sensitive
colloidal
tunability
(e.g.,
smaller
size,
rigidity,
roughness)
robust
(EWDP/Cur)
coloading
capacity
(24.0–33.2%
≫
10%,
pH
2.0–7.0).
Compared
pure
nutraceuticals,
excellent
cellular
absorption
(almost
10
times)
bioavailability
(4.19–5.05
enhancement
via
faster
mucus
permeation
macropinocytosis
transport,
indirectly
regulating
systemic
inflammatory
response.
The
sustainable
sequential
release
targeted
accumulation
profiles
directly
facilitated
interactions
colonic
microenvironment,
verified
intestinal
barrier
recovery
gut
microbiota
restoration.
Moreover,
critical
role
amino
acid
metabolism
reconfirmed
importance
maintaining
homeostasis.
Overall,
this
study
would
provide
facile,
quantitative,
versatile
perspective
into
programmable
design
peptide
EWDP)
coassembled
nanoplatforms
UC.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(38)
Published: May 7, 2024
Abstract
Inflammatory
bowel
disease
(IBD)
encompasses
a
collection
of
chronic
inflammatory
conditions
impacting
the
gastrointestinal
tract,
with
discernible
global
rise
in
prevalence
and
severity.
The
overabundance
reactive
oxygen
species
(ROS)
intestinal
environment
leads
disruption
local
redox
homeostasis,
perturbation
gut
microbiota,
exacerbating
IBD.
Consequently,
mitigating
excess
ROS
preserving
microbiota
homeostasis
have
emerged
as
effective
approaches
for
IBD
management.
In
this
study,
triangular
DNA
origami
nanostructure
loaded
siRNA
targeting
tumor
necrosis
factor
α
(
siTNF‐α
tDON)
is
introduced
purpose.
This
demonstrates
efficacy
eliminating
within
cells
closely
associated
IBD,
diminishing
inflammation,
ameliorating
disorders
evidenced
an
mouse
model.
Furthermore,
investigation
effects
tDON
on
related
signaling
pathways,
including
NF‐κB,
MAPK/ERK
Keap1/Nrf2.
Collectively,
study
offers
insights
into
potential
utilization
nanostructures
antioxidants
modulators,
presenting
promising
avenues
treatment.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(25), P. 31950 - 31965
Published: June 11, 2024
Ulcerative
colitis
(UC)
is
a
recurrent
chronic
mucosal
inflammation
disease
whose
most
significant
pathological
characteristics
are
intestinal
and
damaged
barrier
induced
by
reactive
oxygen/nitrogen
species,
abnormal
immune
microenvironment,
microecological
imbalance.
Oral
probiotics
living
therapy
for
diseases,
but
their
clinical
application
hindered
poor
bacterial
biological
activity
insufficient
retention.
Here,
we
developed
targeted
oral
formulation,
functionalized
probiotic
Lf@MPB,
with
Lactobacillus
fermentum
(Lf)
as
the
core
modified
melanin
nanoparticles
(MNPs)
on
its
surface
through
click
reaction
of
tricarboxyphenylboronic
acid
synergistic
UC.
In
vitro
experiments
showed
that
Lf@MPB
not
only
possessed
strong
free
radical
scavenging
ability,
reduced
cellular
mitochondrial
polarization,
inhibited
apoptosis
also
significantly
enhanced
viability
Lf
in
simulated
gastrointestinal
fluid.
Fluorescence
imaging
vivo
revealed
high
accumulation
at
site
dextran
sulfate
sodium-induced
UC
mice.
Moreover,
results
demonstrated
effectively
alleviated
oxidative
stress
inflammatory
response
restored
barrier.
addition,
16S
rRNA
gene
sequencing
verified
could
increase
abundance
diversity
microbial
communities
optimize
composition
to
inhibit
progression
This
work
combines
effective
antioxidant
anti-inflammatory
strategies
administration
provide
promising
alternative
treatment.
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
373, P. 749 - 765
Published: Aug. 2, 2024
Convincing
evidence
suggests
that
aberrant
gut
microbiota
changes
play
a
critical
role
in
the
progression
and
pathogenesis
of
inflammatory
bowel
disease
(IBD).
Probiotic
therapeutic
interventions
targeting
may
provide
alternative
avenues
to
treat
IBD,
but
currently
available
probiotics
often
suffer
from
low
intestinal
colonization
limited
capability.
Here,
we
developed
azido
(N
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
Abstract
Chemical
reactions
underpin
biological
processes,
and
imbalances
in
critical
biochemical
pathways
within
organisms
can
lead
to
the
onset
of
severe
diseases.
Within
this
context,
emerging
field
“Nanocatalytic
Medicine”
leverages
nanomaterials
as
catalysts
modulate
fundamental
chemical
specific
microenvironments
This
approach
is
designed
facilitate
targeted
synthesis
localized
accumulation
therapeutic
agents,
thus
enhancing
treatment
efficacy
precision
while
simultaneously
reducing
systemic
side
effects.
The
effectiveness
these
nanocatalytic
strategies
critically
hinges
on
a
profound
understanding
kinetics
intricate
interplay
particular
pathological
ensure
effective
catalytic
actions.
review
methodically
explores
situ
their
associated
biomaterials,
emphasizing
regulatory
that
control
responses.
Furthermore,
discussion
encapsulates
crucial
elements‐reactants,
catalysts,
reaction
conditions/environments‐necessary
for
optimizing
thermodynamics
reactions,
rigorously
addressing
both
biophysical
dimensions
disease
enhance
outcomes.
It
seeks
clarify
mechanisms
underpinning
biomaterials
evaluate
potential
revolutionize
across
various
conditions.
The
structural
disruption
of
intestinal
barrier
and
excessive
reactive
oxygen/nitrogen
species
(RONS)
generation
are
two
intertwined
factors
that
drive
the
occurrence
development
ulcerative
colitis
(UC).
Synchronously
restoring
mitigating
excess
RONS
is
a
promising
strategy
for
UC
management,
but
its
treatment
outcomes
still
hindered
by
low
drug
accumulation
retention
in
colonic
lesions.
Inspired
intestine
colonizing
bacterium,
we
developed
mucoadhesive
probiotic
Akkermansia
muciniphila-mimic
entinostat-loaded
hollow
mesopores
prussian
blue
(HMPB)
nanotherapeutic
(AM@HMPB@E)
UC-targeted
therapy
via
repairing
scavenging
RONS.
After
oral
administration,
negatively
charged
AM@HMPB@E
specifically
bind
to
positively
inflamed
colon
lesions
electrostatic
interactions
muciniphila
membrane-mediated
bioadhesion
mechanism.
Subsequently,
superoxide
dismutase
(SOD)-,
catalase
(CAT)-like
HMPB
eliminated
RONS,
thereby
alleviating
RONS-mediated
inflammation
epithelial
damage.
Meanwhile,
UC-site
locally
released
entinostat
could
repair
damaged
inhibiting
endothelial
cell
apoptosis
up-regulating
expression
tight
junctions.
Both
vitro
vivo
results
shown
not
only
exhibited
an
exceptional
site
also
demonstrated
superior
therapeutic
efficacy
compared
first-line
sulfasalazine,
as
evidenced
longer
colon,
less
rectal
bleeding
body
weight
loss.
Collectively,
our
findings
highlight
clinical
application
prospects
this
synchronous
treatment,
offering
paradigm
rational
design
nanomedicine.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 19, 2025
Abstract
The
complex
composition
of
traditional
Chinese
medicines
(TCMs)
has
posed
challenges
for
in‐depth
study
and
global
application,
despite
their
abundance
bioactive
compounds
that
make
them
valuable
resources
disease
treatment.
To
overcome
these
obstacles,
it
is
essential
to
modernize
TCMs
by
focusing
on
precise
This
involves
elucidating
the
structure‐activity
relationships
within
compositions,
ensuring
accurate
in
vivo
delivery,
monitoring
delivery
process.
review
discusses
research
progress
precision
treatment
from
three
perspectives:
spatial
multi‐omics
technology
therapeutic
activity,
carrier
systems
medical
imaging
visualizing
aim
establish
a
novel
paradigm
advances
therapy
TCMs.